Latest Articles

Kerry Taylor-Smith explores the latest advances in synthetic biology, from the development of new agricultural biotechnology tools to therapeutics and diagnostics.

Technology Networks invited Dr. Heifets, assistant professor at the Stanford School of Medicine, to an Ask Me Anything session to answer your questions about psychedelics.

Technology Networks invited chief editor at Nature Biotechnology, Barbara Cheifet, to an Ask Me Anything session to answer questions about the biggest challenges in scientific publishing and how to get work published in high-ranking journals.

Immune cells come in many shapes and sizes and with numerous different properties. In this article, we consider what eosinophils are, how they are generated, their function in the body and medical conditions related to them, including eosinophilia.

The impetus to demonstrate regulatory compliance to ensure their products are safe for human consumption is an imperative for pharmaceutical and biotechnology organizations.

Thanks to the rise of AI, HTS for drug discovery is taking a more intelligent, computational approach, with tools that allow scientists to pinpoint the most promising drug candidates faster. Explore how this evolution will be further enhanced by a shift from 2D to 3D biological models such as organoids.

Using data provided by Intercontinental Exchange, My Green Lab has produced a report providing key insights into the current state of the sector’s carbon emissions. James Connelly highlights some of the key findings and their significance.

This article explores several examples of how comprehensive modeling tools and expert guidance can help determine what specific adaptations can optimize trials.

Two-dimensional liquid chromatography (2D-LC) offers extra separation power for complex and challenging samples and now has an important place in industry as well academia thanks to important advances. But this is by no means the end of the story.

Chronic sleep disruption (CSD) has been shown to promote pain. Now, a team of scientists have shed light on some of the brain regions and signaling molecules that may be responsible, offering potential avenues for therapeutic investigation.